Delivery Order SPE2DB20D1109-SPE2DB25FP68G
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on April 24, 2025, with a ceiling value of $12,746.53. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $13,614.03. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive procurement without set-aside designation,...
- The Defense Logistics Agency awarded a $10,274.35 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). The contract utilizes firm fixed-price terms and is classified as a non-competitive, non-set-aside award. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,018.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $11.89K delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, firm fixed-price delivery order is set to be completed by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP68GDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8-pack quantity) valued at $14,310.29 under a firm fixed price contract. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is part of AmerisourceBergen's extensive pharmaceutical supply portfolio supporting military and federal healthcare systems. NURTEC ODT is a prescription migraine medication used within the Defense Health Agency and broader military medical supply chain. The underlying IDC with DLA serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's consistent receipt of competitively awarded contracts and its substantial prime vendor status demonstrate its established capability to fulfill critical federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 9/3/25 |